Coactivation of nuclear receptors
View Patent ↗The invention provides a protein having an amino acid sequence as in SEQ ID 7, 8, 11 or 12, similar proteins, naturally occurring variants and homologous functional equivalents thereof, as well as the use of a polynucleotide encoding such protein, for use in an assay and for use in a method of modulation of transcriptional activity promoted by a responsive nuclear receptor and a coactivator, which coactivator is the mentioned protein and is named COASTER, and which nuclear receptor is preferrably a steroid receptor.
1. An in vitro screening method for determining the transcription modulating activity of an agent, comprising:
providing a cell-based transcription system comprising a coactivator having at least 95% similarity with amino acids 1-234 of SEQ ID NO:7 or amino acids 1-234 of SEQ ID NO:8, a nuclear receptor responsive to the coactivator and a reporter gene whose transcription is promoted by the combination of the responsive nuclear receptor and the coactivator;
adding the agent to the cell-based transcription system;
quantifying the degree of transcription of the reporter gene in the presence of the agent; and
comparing the degree of transcription of the reporter gene in the presence of the agent with the degree of transcription of the reporter gene in the absence of the agent, thereby determining the transcription modulating activity of the agent.
2. The in vitro screening method of claim 1 , wherein the coactivator has at least 95% similarity with amino acids 1-234 of SEQ ID) NO:7.
3. The in vitro screening method of claim 2 , wherein the responsive nuclear receptor is a steroid receptor.
4. The in vitro screening method of claim 3 , wherein the steroid receptor is selected from the group consisting of a progesterone receptor, an estrogen receptor and a glucocorticoid receptor.
5. The in vitro screening method of claim 2 , wherein the coactivator has at least 95% similarity with SEQ ID NO:7.
6. The in vitro screening method of claim 5 , wherein the responsive nuclear receptor is a steroid receptor.
7. The in vitro screening method of claim 6 , wherein the steroid receptor is selected from the group consisting of a progesterone receptor, an estrogen receptor and a glucocorticoid receptor.
8. The in vitro screening method of claim 5 , wherein the coactivator is SEQ ID NO:7.
9. The in vitro screening method of claim 8 , wherein the responsive nuclear receptor is a steroid receptor.
10. The in vitro screening method of claim 9 , wherein the steroid receptor is selected from the group consisting of a progesterone receptor, an estrogen receptor and a glucocorticoid receptor.
11. The in vitro screening method of claim 1 , wherein the coactivator has at least 95% similarity with amino acids 1-234 of SEQ ID NO:8.
12. The in vitro screening method of claim 11 , wherein the responsive nuclear receptor is a steroid receptor.
13. The in vitro screening method of claim 12 , wherein the steroid receptor is selected from the group consisting of a progesterone receptor, an estrogen receptor and a glucocorticoid receptor.
14. The in vitro screening method of claim 11 , wherein the coactivator has at least 95% similarity with SEQ ID NO:8.
15. The in vitro screening method of claim 14 , wherein the responsive nuclear receptor is a steroid receptor.
16. The in vitro screening method of claim 15 , wherein the steroid receptor is selected from the group consisting of a progesterone receptor, an estrogen receptor and a glucocorticoid receptor.
17. The in vitro screening method of claim 14 , wherein the coactivator is SEQ ID NO:8.
18. The in vitro screening method of claim 17 , wherein the responsive nuclear receptor is a steroid receptor.
19. The in vitro screening method of claim 18 , wherein the steroid receptor is selected from the group consisting of a progesterone receptor, an estrogen receptor and a glucocorticoid receptor.